![]() There is a 6-month, single-arm, open-label period after completion of the 6-month double- masked, controlled period allows the evaluation of the efficacy and safety of intravitreal injection of DE-109 440 µg every 2 months for longer duration than appropriate for a placebo or sham control.Īn Open Label, Multi-centered, Randomized Phase 2 Study to Evaluate the Safety, Tolerability and Bioactivity of Subcutaneous ACTH GeL in PAtients with Scleritis (The ATLAS Study) This is a Phase III study to assess the efficacy and safety of DE-109 440 µg every 2 months in subjects with active, non-infectious uveitis of the posterior segment of the eye (NIU-PS). LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye The main goal of this project is to conduct a prospective observational cohort study to determine the financial burden of herpes zoster ophthalmicus (also referred to as HZO or zoster eye disease) patients in the United States Zoster Burden of Eye Disease: A Prospective Observational Cohort Study of Major U.S. The purpose of this research study is to investigate the safety and effectiveness of the investigational study eye drops (0.75% phentolamine ophthalmic solution) eye drops, when used once daily in the evening up to 15 days. RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-MASKED STUDY OF THE SAFETY AND EFFICACY OF NYXOL (0.75% PHENTOLAMINE OPHTHALMIC SOLUTION) IN SUBJECTS WITH DIM LIGHT VISION DISTURBANCES Expected to have Cataract surgery with no active or a history of chronic or recurrent inflammatory eye disease (e.g., iritis, scleritis, uveitis, iridocyclitis, rubeosis iridis) in the study eye. The purpose of the study is to find out how well the active study drug APP13007 eye drops, works and how safe the drug is when it is used to treat inflammation and pain after Cataract Sx compared to an inactive placebo Lumina eye drops trial#If you are interested in any of these trials, please contact our Clinical Trial Coordinator at 20 ext 125 or 20, or email us Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain after Cataract Surgery, Including a Corneal Endothelial Cell Sub-study. ![]() The best interest of patients is always our priority and patients will always have direct communications with our study staff. Patients are extremely carefully monitored to ensure the safety. Patient selection and visits are rigorous to ensure efficacy for the participants. In patients with complex ocular problems, if indicated, a clinical trial may offer our patients the chance to receive treatments that are not available elsewhere.Ĭlinical trials are not for everyone. We are actively participating in several FDA sanctioned clinical trials, as well as numerous IRB approved clinical studies. We strive to offer the latest knowledge and cutting-edge medical technology to our patients for treatment of their conditions. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |